Evidence map›Paper›PMID 31938304›Full record

ArticleInternational journal of clinical and experimental pathology2018

Interferon epsilon mRNA expression could represent a potential molecular marker in cervical cancer.

Daniel Marrero-Rodríguez, Victor Baeza-Xochihua, Keiko Taniguchi-Ponciano, Victor Huerta-Padilla, Gustavo Ponce-Navarrete, Alejandra Mantilla, Daniel Hernandez, Angeles Hernandez, Guillermo Gomez-Gutierrez, Luis Serna-Reyna and 10 more

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Interferon Epsilon: Properties and Functions.Current molecular medicine · 2025
    Review
  2. Article
  3. Article
  4. Pathways of IFN-alpha Activation in Patients with Cervical Intraepithelial Neoplasia (CIN).Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Daniel Marrero-RodríguezLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN-SXXI, IMSS México D.F. 06720, México.
Victor Baeza-XochihuaLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN-SXXI, IMSS México D.F. 06720, México.
Keiko Taniguchi-PoncianoLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN-SXXI, IMSS México D.F. 06720, México.
Victor Huerta-PadillaLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN-SXXI, IMSS México D.F. 06720, México.
Gustavo Ponce-NavarreteLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN-SXXI, IMSS México D.F. 06720, México.
Alejandra MantillaServicio de Patología, Hospital de Oncología CMN-SXXI, IMSS Mexico.
Daniel HernandezDivisión de Laboratorios de Vigilancia e Investigación Epidemiológica, IMSS México, D.F., México.
Angeles HernandezDivisión de Laboratorios de Vigilancia e Investigación Epidemiológica, IMSS México, D.F., México.
Guillermo Gomez-GutierrezClínica de Displasias, Hospital General de México México, D.F., México.
Luis Serna-ReynaClínica de Displasias, Hospital General de México México, D.F., México.
Ma Del Pilar Figueroa-CoronaDepartamento de Biomedicina Molecular, CINVESTAV Mexico D.F. 07360, México.
Laura Gomez-VirgilioDepartamento de Biomedicina Molecular, CINVESTAV Mexico D.F. 07360, México.
Miriam Rodriguez-EsquivelLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN-SXXI, IMSS México D.F. 06720, México.
Pablo Romero-MorelosLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN-SXXI, IMSS México D.F. 06720, México.
Miguel A Vazquez-MorenoUnidad de Investigación Medica en Bioquimica, Hospital de Especialidades, CMN-SXXI, IMSS México, D.F., México.
Sarahi Loza-MedranoUnidad de Investigación Medica en Bioquimica, Hospital de Especialidades, CMN-SXXI, IMSS México, D.F., México.
Jorge Ortiz-LeonClínica de Displasias, Hospital General de México México, D.F., México.
Edgar Hernandez-RicoUniversity of Texas at El Paso El Paso, Texas, United States of America.
Marco Meraz-RiosDepartamento de Biomedicina Molecular, CINVESTAV Mexico D.F. 07360, México.
Mauricio SalcedoLaboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN-SXXI, IMSS México D.F. 06720, México.
Mexican Social Security Institute · MXCentro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXHospital General de México · MXDepartamento de Epidemiología · GTHospital de Especialidades · MXThe University of Texas at El Paso · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of the immune system response in the malignant transformation process have been described. Molecules such as interferons are involved in such process. Interferons are small single-chained glycoproteins, involved in the first line of defense against pathogens such as viruses, bacteria, and parasites. Interferon epsilon (IFNε) is located in the 9p21.3 cytogenetic region, transcribes into a single exon mRNA. Contrary to other family members, IFNε exerts low antiviral activity. In the present work molecular alterations such as copy number variation (CNV) and expression were analyzed by available microarrays and fifty-nine cervical tissues ranging from normal to cancer and three cell lines were assessed for IFNε expression by RT-PCR, immunohistochemistry, and immunocytofluorescence. No significant CNV alterations were observed. Positive immunosignal was primarily present in the proliferative basal strata cells in the normal tissue, whereas in cervical cancer, all epithelial transformed cells were positive. The cell lines analyzed were HPV16, -18, and negative, all three cell-lines were positive for cytoplasmic protein presence. Interestingly, at the mRNA level, increased band intensity was observed, as the lesions were higher, and IFNε up-regulation in CC (

Indexed as

Cervical cancercytokinesinterferon epsilonmolecular marker

Identifiers

PMID31938304
PMCPMC6958218
OpenAlexW3018076765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.